{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:49:16Z","timestamp":1759366156193,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.arteri.2019.01.006","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T19:57:42Z","timestamp":1555531062000},"page":"282-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluaci\u00f3n del riesgo hemorr\u00e1gico de la terapia antitromb\u00f3tica en pacientes con ictus"],"prefix":"10.1016","volume":"31","author":[{"given":"Luis","family":"Castilla-Guerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Carmen","family":"Fern\u00e1ndez-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"de la Vega-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Leon Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2019.01.006_bib0170","unstructured":"Instituto Nacional de Estad\u00edstica. Estad\u00edstica de defunciones seg\u00fan la causa de muerte 2016 [consultado Dic 2017]. Disponible. en:http:\/\/www.ine.es\/dyngs\/INEbase\/es\/operacion.htm?c=Estadistica_C&cid=1254736176780&menu=ultiDatos&idp=1254735573175"},{"key":"10.1016\/j.arteri.2019.01.006_bib0175","unstructured":"Instituto Nacional de Estad\u00edstica. Encuesta de morbilidad hospitalaria 2015 [consultado Dic 2017]. Disponible en: http:\/\/www.ine.es\/jaxi\/Datos.htm?path=\/t15\/p414\/a2015\/l0\/&file=01003.px"},{"key":"10.1016\/j.arteri.2019.01.006_bib0180","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1161\/STROKEAHA.110.602615","article-title":"Risk and cumulative risk of stroke recurrence: A systematic review and metaanalysis","volume":"42","author":"Mohan","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2019.01.006_bib0185","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular auricular fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.arteri.2019.01.006_bib0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.carrev.2016.07.006","article-title":"Long-term use of dual antiplatelet therapy for the secondary prevention of atherothrombotic events: Meta-analysis of randomized controlled trials","volume":"18","author":"Fanari","year":"2017","journal-title":"Cardiovasc Revasc Med."},{"key":"10.1016\/j.arteri.2019.01.006_bib0195","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11239-013-0899-7","article-title":"Assessing bleeding risk in patients taking anticoagulants","volume":"35","author":"Shoeb","year":"2013","journal-title":"J Thromb Thrombolysis."},{"key":"10.1016\/j.arteri.2019.01.006_bib0200","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and metaanalysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"McQuaid","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.arteri.2019.01.006_bib0205","doi-asserted-by":"crossref","unstructured":"Swedish aspirin low-dose trial (SALT) of 75mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT collaborative group. Lancet 1991;338:1345-1349.","DOI":"10.1016\/0140-6736(91)92233-R"},{"key":"10.1016\/j.arteri.2019.01.006_bib0210","doi-asserted-by":"crossref","unstructured":"CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE steering committee. Lancet 1996;348:1329-1339.","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"10.1016\/j.arteri.2019.01.006_bib0215","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/jnnp.2004.059923","article-title":"Predictors of risk of intracerebral haemorrhage in patients with a history of TIA or minor ischaemic stroke","volume":"77","author":"Ariesen","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.arteri.2019.01.006_bib0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000453459","article-title":"PERFORM and PRoFESS Committees and Investigators The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet Treatment","volume":"43","author":"Amarenco","year":"2017","journal-title":"Cerebrovasc Dis."},{"key":"10.1016\/j.arteri.2019.01.006_bib0225","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(11)60600-4","article-title":"Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): A randomised, double-blind, parallel-group trial","volume":"377","author":"Bousser","year":"2011","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2019.01.006_bib0230","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2019.01.006_bib0235","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/WNL.0000000000004289","article-title":"Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets: S2TOPBLEED","volume":"89","author":"Hilkens","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.arteri.2019.01.006_bib0240","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/STROKEAHA.117.019259","article-title":"External validation of risk scores for major bleeding in a population-based cohort of transient ischemic attack and ischemic stroke patients","volume":"49","author":"Hilkens","year":"2018","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2019.01.006_bib0245","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel userfriendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with auricular fibrillation: The Euro Heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.arteri.2019.01.006_bib0250","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J."},{"key":"10.1016\/j.arteri.2019.01.006_bib0255","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2019.01.006_bib0260","first-page":"3258","volume":"36","author":"O\u2019Brien","year":"2015","journal-title":"The ORBIT Bleeding Score: A simple bedside score to assess bleeding risk in auricular fibrillation Eur Heart J."},{"key":"10.1016\/j.arteri.2019.01.006_bib0265","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with auricular fibrillation: A derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2019.01.006_bib0270","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2019.01.006_bib0275","first-page":"421","article-title":"Evaluacion del riesgo de sangrado en pacientes con fibrilaci\u00f3n auricular no valvular","volume":"24","author":"Pulido-Medina","year":"2017","journal-title":"Rev Colom Cardiol"},{"key":"10.1016\/j.arteri.2019.01.006_bib0280","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/clc.22435","article-title":"The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis","volume":"38","author":"Zhu","year":"2015","journal-title":"Clin Cardiol."},{"key":"10.1016\/j.arteri.2019.01.006_bib0285","first-page":"1170","article-title":"Focused update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation","volume":"32","author":"Macle","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.arteri.2019.01.006_bib0290","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/IJGM.S109104","article-title":"Minimizing bleeding risk in patients receiving direct oral anticoagulants for stroke prevention","volume":"9","author":"Habert","year":"2016","journal-title":"Int J Gen Med."},{"key":"10.1016\/j.arteri.2019.01.006_bib0295","first-page":"9","article-title":"Evaluaci\u00f3n de riesgo tromboemb\u00f3lico y hemorr\u00e1gico de los pacientes con fibrilaci\u00f3n auricular","volume":"13","author":"Guindo Soldevila","year":"2013","journal-title":"Rev Esp Cardiol Supl."},{"key":"10.1016\/j.arteri.2019.01.006_bib0300","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1631\/jzus.B1600143","article-title":"Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in auricular fibrillation patients: A systematic review and network meta-analysis","volume":"18","author":"Xu","year":"2017","journal-title":"J Zhejiang Univ Sci B."},{"key":"10.1016\/j.arteri.2019.01.006_bib0305","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/1747493017700663","article-title":"Nonvitamin-K antagonist oral anticoagulants versus warfarin in patients with auricular fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Ntaios","year":"2017","journal-title":"Int J Stroke."},{"key":"10.1016\/j.arteri.2019.01.006_bib0310","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with auricular fibrillation: The Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2019.01.006_bib0315","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/STROKEAHA.113.004506","volume":"45","author":"Hankey","year":"2014","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2019.01.006_bib0320","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11886-014-0480-9","article-title":"Intracranial hemorrhage and novel anticoagulants for atrial fibrillation: What have we learned?","volume":"16","author":"Hankey","year":"2014","journal-title":"Curr Cardiol Rep."},{"key":"10.1016\/j.arteri.2019.01.006_bib0325","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.01.019","article-title":"Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: A population-based cohort study","volume":"22","author":"Seet","year":"2013","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"10.1016\/j.arteri.2019.01.006_bib0330","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","volume":"60","author":"Apostolakis","year":"2012","journal-title":"J Am Coll Cardiol."}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916819300221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916819300221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:31:35Z","timestamp":1759325495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916819300221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0214916819300221"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2019.01.006","relation":{},"ISSN":["0214-9168"],"issn-type":[{"type":"print","value":"0214-9168"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluaci\u00f3n del riesgo hemorr\u00e1gico de la terapia antitromb\u00f3tica en pacientes con ictus","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2019.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}